Showing results (161-170 of 447) with videos related to

Sort By:
Pageof 45
Asia-Pacific Journal of Clinical Oncology|March 8, 2016
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patientsYoshinori Makino, Michiko Watanabe, Reiko Ando Makihara, et al.
Respirology (Carlton, Vic.)|October 6, 2017
Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talcYuki Shinno, Hidenori Kage, Haruka Chino, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|March 6, 2018
[The nutritional and dietary intake among community-dwelling elderly female users of mobile vendor vehicles]Yukio Yoshimura, Hideki Ito, Hidenori Yoshimura, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC)Satoshi Ishikura, Yuichiro Ohe, Keiji Nihei, et al.
The Annals of Thoracic Surgery|November 29, 2021
Salvage Surgery Compared to Surgery After Induction Chemoradiation Therapy for Advanced Lung CancerAki K Kobayashi, Kazuo Nakagawa, Yuko Nakayama, et al.
Japanese Journal of Clinical Oncology|March 24, 2022
The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance studyYuichiro Ohe, Naoya Yamazaki, Nobuyuki Yamamoto, et al.
Clinical Lung Cancer|May 29, 2012
Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus Cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancerSeiji Niho, Kaoru Kubota, Keiji Nihei, et al.
Clinical Lung Cancer|November 13, 2020
Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLCYuki Takeyasu, Tatsuya Yoshida, Ryota Shibaki, et al.
Japanese Journal of Clinical Oncology|August 12, 2006
Pharmacokinetics and pharmacodynamics of weekly epoetin beta in lung cancer patientsYasuhito Fujisaka, Tomohide Tamura, Yuichiro Ohe, et al.
Cancer Science|November 13, 2003
Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patientsHirokazu Watanabe, Seiichiro Yamamoto, Hideo Kunitoh, et al.
Pageof 45